INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

77,304 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
LB
Lewis BryanDirector, CEO/President
IDNIntellicheck, Inc.
Open-market sale · 10b5-1 plan
SELL$85K
10.0K sh
Apr 20, 2026Apr 21, 2026
Page 1104 of 1933
← PrevNext →
traded Apr 20, 2026
+1d
SEC Form 4

Evidence

8
LJ
Lodge-Jarrett JulieEVP, Chf People & Purpose Ofcr
DKSDICK'S SPORTING GOODS, INC.
Gift
G—
150 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
PP
Priest Brady PatrickCEO of Clover Care Services
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$79K
36.1K sh
Apr 18, 2026Apr 21, 2026
traded Apr 18, 2026
+3dSEC Form 4

Evidence

8
AC
Ames Sophie CExec. Vice President & CHRO
QBTSD-Wave Quantum Inc.
Open-market sale · 10b5-1 plan
SELL$66K
3,070 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
GL
Gibbons Mary LourdesSVP and Chief Legal Officer
ESNTEssent Group Ltd.
Open-market sale · 10b5-1 plan
SELL$55K
872 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$806K
1,398 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$115K
2,419 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
GJ
Garateix Ernie JDirector, Chief Executive Officer
HRTGHeritage Insurance Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
8,034 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$885K
1,543 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

7
GL
Gibbons Mary LourdesSVP and Chief Legal Officer
ESNTEssent Group Ltd.
Open-market sale · 10b5-1 plan
SELL$481K
7,628 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

7
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Open-market sale · 10b5-1 plan
SELL$355K
23.7K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
BJ
Binder Kurtis JosephCHIEF FINANCIAL OFFICER
ARLOArlo Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$380K
25.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
BL
Bradbury Robyn LChief Financial Officer
CNMCore & Main, Inc.
Derivative conversion · 10b5-1 plan
C—
5,000 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
SP
Sharma PankajChief Business Officer
RELYRemitly Global, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
RJ
Riese Phillip JohnDirector
RELYRemitly Global, Inc.
Option exercise · 10b5-1 plan
M$26K
40.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
KE
Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Open-market sale · 10b5-1 plan
SELL$26K
536 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
PM
Pearson MarkDirector, President and CEO
EQHEquitable Holdings, Inc.
Option exercise · 10b5-1 plan
M$630K
27.2K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,477
62 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
GS
Ganesan SatishSee Remarks
SYNASYNAPTICS Inc
Tax withholding · 10b5-1 plan
F$470K
5,862 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
GJ
Garateix Ernie JDirector, Chief Executive Officer
HRTGHeritage Insurance Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,521
300 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

5
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Tax withholding · 10b5-1 plan
F$443K
5,518 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$589K
1,009 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$289K
500 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$581K
1,010 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$573K
983 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
HM
Hoffmann MartinCEO
ONONOn Holding AG
Open-market sale · 10b5-1 plan
SELL$152K
4,150 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$254K
442 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$397K
687 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$504K
880 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$284K
488 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$282K
482 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

3
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
416 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

3
AN
Atkinson NajumaDirector
MQMarqeta, Inc.
Option exercise · 10b5-1 plan
M—
30.9K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

3
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$12K
5,000 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

3
RJ
Riese Phillip JohnDirector
RELYRemitly Global, Inc.
Option exercise · 10b5-1 plan
M—
40.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

2
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Grant or award · 10b5-1 plan
A—
822.0K sh
Apr 16, 2026Apr 21, 2026
traded Apr 16, 2026
+5dSEC Form 4

Evidence

2
BL
Bradbury Robyn LChief Financial Officer
CNMCore & Main, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
5,000 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

2
BL
Bradbury Robyn LChief Financial Officer
CNMCore & Main, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
5,000 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

1
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$197K
340 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

1
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,413
140 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence